Letter to Pharma Companies Urging Collaborative Approach in Covid-19 Response
The below letter was sent to the following pharmaceutical companies by ICCR members on April 1, 2020 AbbVie; Amgen; Biogen; Bristol-Myers Squibb; Gilead; GSK; Eli Lilly; Johnson & Johnson; Merck; Pfizer; Novartis; Roche; Sanofi; Vertex